This page is part of the FHIR Specification (v4.6.0: R5 Draft Ballot). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Patient, Practitioner, RelatedPerson |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile AllergyIntolerance.
Generated Narrative
identifier: id: 49476534
clinicalStatus: Active
verificationStatus: Confirmed
type: allergy
category: food
criticality: high
code: Cashew nuts
onset: 2004
recordedDate: 9 Oct. 2014, 2:58:00 pm
recorder: Generated Summary: id: 23; active; Adam Careful
lastOccurrence: 2012-06
note: The criticality is high becasue of the observed anaphylactic reaction when challenged with cashew extract.
reaction
substance: cashew nut allergenic extract Injectable Product
Manifestations
- * description: Challenge Protocol. Severe reaction to subcutaneous cashew extract. Epinephrine administered
onset: 2012-06-12
severity: severe
exposureRoute: Subcutaneous route
reaction
Manifestations
- * onset: 2004
severity: moderate
note: The patient reports that the onset of urticaria was within 15 minutes of eating cashews.
Other examples that reference this example:
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.